Search

everythinglearnresearchcommunity

for

Search:↓

High TSPEAR levels in colorectal cancer predict worse outcomes.

Older age and existing health issues increase COVID-19 death risk.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Age, health conditions, race, and gender affect COVID-19 risk.

Antioxidant-rich diets may reduce hair loss risk, while pro-inflammatory diets may increase it, especially in women.

People with alopecia areata may have a higher risk of hearing loss.

Early recognition and treatment of Peripheral Arterial Disease is crucial to improve survival and health outcomes.

Androgenetic alopecia is linked to a higher risk of varicose veins, especially in men, but not to major vascular diseases.

PAD is common but often missed, needing lifestyle changes and medication for better outcomes.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

COVID-19 generally causes fewer complications than influenza, except for certain conditions like hair loss and heart issues.